|
|
||||||||
1 Department of Internal Medicine and 3 Department of Pharmacology, University of California at Davis, Davis, California 95616; and 2 Department of Anatomy and Brain Science, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
| |
ABSTRACT |
|---|
|
|
|---|
A single bout of
exercise results in a postexercise hypotension (PEH) that is
accompanied by a reduced baroreflex function. Based on the role of
rostral ventrolateral medulla (RVLM) neurons in controlling sympathetic
nerve activity (SNA) and blood pressure, the role of
-aminobutyric
acid (GABA) in controlling RVLM neuronal activity, and the reduced
baroreflex-SNA relationship during PEH, we determined whether:
1) RVLM neuronal activity is decreased during PEH,
2) GABAA-receptor mechanisms mediate the
decrease, and 3) baroreflex control of RVLM activity is
reduced. Spontaneously hypertensive rats (SHR) were subjected to 40 min
of treadmill or sham exercise (Sham PEH). PEH lasted 10 h in
conscious and anesthetized SHR, indicating that the anesthetics did not
affect the expression of PEH. Extracellular RVLM neuronal activity
having a cardiac and sympathetic rhythm, lumbar SNA, and blood pressure were recorded at rest and during baroreflex function curves. Resting RVLM neuronal activity was lower and was increased to a greater extent
by GABAA-receptor antagonism in PEH versus Sham PEH
(P < 0.05). Baroreflex control of RVLM neuronal
activity operated with a reduced gain (P < 0.05). Thus
increased GABA signaling at RVLM neurons may contribute to PEH.
spontaneously hypertensive rats; central sympathetic network; extracellular recording
| |
INTRODUCTION |
|---|
|
|
|---|
HYPERTENSION is a major antecedent of stroke, heart failure, and end-stage renal disease. After decades of improvement in its control with pharmacological treatments, national reports now indicate that hypertension is adequately controlled in only about 25% of individuals in the United States (55). This downward trend in pharmacological management has led to renewed efforts to reduce the prevalence of hypertension with nonpharmacological approaches (5). In individuals with hypertension, a single bout of mild to moderate dynamic exercise can lead to a postexercise decrease in blood pressure (7, 13, 20, 28-30, 35, 48). This phenomenon, termed postexercise hypotension (PEH), can restore blood pressure back toward normal (30, 35) and can persist for up to 12 h (19, 30). Understanding the mechanisms of PEH may be a first step in increasing an awareness of this strategy for controlling hypertension and might lead to a greater emphasis on lifestyle modification compared with a sole reliance on pharmacological therapy. The spontaneously hypertensive rat (SHR) appears to be an ideal model for investigating the mechanisms; following single bouts of mild to moderate exercise (treadmill or spontaneous wheel running), SHR exhibit PEH of the same magnitude and duration observed in hypertensive humans (10, 14, 38, 43).
Both neural and humoral changes have been explored in hypertensive humans and SHR to help explain PEH; these include activation of the endogenous opioid system (8, 9), enhanced cardiopulmonary reflex-mediated sympathoinhibition (14), reduced vascular resistance (13, 29, 32, 33, 38) and reactivity (33), or thermoregulatory-induced increases in skin blood flow (21).
There are two salient characteristics of PEH: 1) a reduction
in sympathetic nerve activity (20, 29, 32, 38) and
2) a requirement for an intact baroreflex system
(10). To begin to unravel the mechanisms underlying PEH, a
good starting point is to determine the mechanism for the reduced
sympathetic nerve discharge. There is now considerable evidence that
sympathetic nerve activity is generated by a group of neurons in the
rostral ventrolateral medulla (RVLM) and that cardiovascular reflex and central descending changes in sympathetic nerve activity and arterial blood pressure (ABP) are relayed through these neurons
(27). These RVLM neurons, characterized by their
sympathetic-related rhythm and cardiac rhythm from entrainment by
baroreceptor input (27), are under a tonic inhibition,
largely mediated by
-aminobutyric acid (GABA) acting at
GABAA receptors (2, 15, 24, 26, 40, 45). In
that regard, blockade of GABAA receptors in the RVLM can
increase the baseline activity of the individual RVLM neurons
(23) and can also increase sympathetic nerve activity and
arterial blood pressure (25, 47, 54, 61). The GABA-ergic input arises mostly from baroreceptor reflex pathways through the
nucleus tractus solitarius and caudal ventrolateral medulla (2,
15, 24, 26, 45); but there is also evidence for a GABA-ergic
inhibitory input independent of the baroreceptors (40).
Thus GABA-ergic mechanisms in the RVLM could contribute to the
development of PEH.
Regarding the second salient feature of PEH (i.e., the requirement for an intact baroreflex system), while the baroreflex system is essential, regulatory events in the reflex pathway must be altered, given that sympathetic nerve activity is reduced rather than elevated as might be expected during the lower ABP. Studies in humans and SHR report significant decreases in muscle sympathetic nerve activity, associated with a downward and leftward shift of the baroreflex-sympathetic nerve activity relationship (11, 29). These findings raise the possibility of a centrally mediated reduced gain and resetting of the baroreflex system, which might be expected to manifest at RVLM neurons.
Thus, based on the fundamental role of the RVLM neurons in controlling sympathetic vasomotor tone and blood pressure, the regulatory role of GABA in controlling the baseline activity of those neurons and the reduced baroreflex function during PEH, the purpose of this study was to address three questions: 1) Does a decrease in RVLM cardiovascular sympathetic neuronal activity accompany PEH? 2) Is the reduced RVLM sympathetic output (and hence PEH) mediated by an increase in RVLM GABAA-receptor mechanisms? 3) Does a reduced gain of the baroreflex-control of RVLM neuronal activity contribute to the decreased gain in the baroreflex-sympathetic nerve activity relationship?
| |
METHODS |
|---|
|
|
|---|
All experimental protocols in this work were reviewed and approved by the Institutional Animal Care and Use Committee in compliance with the Animal Welfare Act and in accordance with Public Health Service Policy on Humane Care and Use of Laboratory Animals.
All experiments were performed in male SHR (250-350 g; Charles River Laboratories) randomly assigned to an exercise group (PEH) that were subjected to a single bout of exercise on a motor-driven treadmill at 15 m/min, 10° for 40 min or to a sham-exercise group (Sham PEH) placed on the treadmill for 40 min with no exercise.
Studies on PEH in conscious and anesthetized SHR. In preliminary experiments, the time course of PEH and the effect of anesthetic on the expression of PEH were examined. SHR were anesthetized with ketamine (50 mg/kg) and xylazine (8 mg/kg), and a catheter was inserted via the left carotid artery and advanced to the descending aorta. The other end of the catheter was tunneled beneath the skin and exteriorized at the back of the neck for recording ABP and mean ABP (MABP). The rats were allowed 3-5 days to recover from surgery and were then randomly assigned in a crossover design to PEH or Sham PEH groups. The rats were further divided into anesthetic and nonanesthetic (conscious) groups. One SHR studied in the conscious state was also studied in the anesthetized state.
On the day of the experiment, each rat was placed on the treadmill, and the arterial catheter was connected to a blood pressure transducer. The rats were on the treadmill for a minimum of 40 min and up to 60 min before the exercise or sham exercise was commenced. During the preexercise period, a MABP reading was taken over a 10- to 20-s period every 10 min. After three consecutive MABP readings that were within 10%, the rat was subjected to exercise or sham exercise. MABP was measured every 10 min during the 40 min of exercise or sham exercise and over the next 10 h after exercise or sham exercise in both conscious and anesthetized SHR. After exercise or sham exercise, rats in the conscious PEH and Sham PEH groups were returned to their individual home cages, and rats in the anesthetic group were anesthetized (intraperitoneally) with an initial dose of a mixture of
-chloralose (80 mg/kg) and urethane (500 mg/kg). The adequacy of
anesthesia was assessed every 20-30 min by pinching the hindlimb
paw and monitoring for hindlimb flinch or for fluctuations in ABP (>5
mmHg). When needed, supplemental doses of
-chloralose (16 mg/kg ia)
and urethane (100 mg/kg ia) were given.
General animal preparation for neuronal recordings in
anesthetized SHR.
Immediately after the exercise or sham exercise, each rat was
anesthetized (intraperitoneally) with an initial dose of a mixture of
-chloralose (80 mg/kg) and urethane (500 mg/kg). When needed, supplemental doses of
-chloralose (16 mg/kg iv) and urethane (100 mg/kg iv) were given. The adequacy of anesthesia was assessed every
20-30 min by pinching the hindlimb paw and monitoring for hindlimb
flinch or for fluctuations in MABP (>5 mmHg) or heart rate (HR)
(>10%). After the initial anesthetic dose, a catheter was inserted
into the tail vein for intravenous administration of supplementary
doses of anesthetic and a constant infusion of intravenous fluids
(8.4% sodium bicarbonate, 0.05 ml/min, and a mixture of 5% dextrose
and 0.2% sodium chloride, 0.06 ml/min). A catheter was inserted into
the femoral artery and advanced to the abdominal aorta to record ABP
and withdraw samples for monitoring arterial blood gases. Three hundred
microliters of arterial blood were taken for blood gas measurement
every 30 min at the beginning of the experiment and every 2-3 h
once the blood gases were stabilized. Arterial blood gases were
maintained within normal limits (pH: 7.35-7.45,
PCO2: 35-45 mmHg,
PO2: >100 mmHg) by adjusting the ventilation
rate or infusing sodium bicarbonate. Two catheters were advanced into
the inferior vena cava via the femoral veins for the administration of
nitroprusside and phenylephrine for generating baroreflex function
curves. The trachea was cannulated below the larynx, and each rat was
mechanically ventilated with oxygen-enriched air and placed on 2 cmH2O positive end-expiratory pressure. Rectal temperature
was maintained at 37 ± 1°C with a servo-controlled water
blanket and heat lamp. Electrocardiogram (ECG) was recorded with
subcutaneous electrodes for monitoring HR and generating R-wave
triggered averages of neuronal activity, ABP, and lumbar sympathetic
nerve (LSN) activity. The LSN was isolated by an abdominal approach to
expose the lumbar sympathetic chain between L3 and
L5, placed on a bipolar hook electrode, and embedded in
silicone gel (Wacker Sil-Gel 604). After solidification of the gel, the
abdomen was sutured closed, and the animal was returned to a prone
position. Multifiber LSN activity (LSNA) was fed via a high-impedance
source follower to second-stage amplifier, filtered with a 1- to
3,000-Hz bandpass to reveal slow wave peaks of activity and fed in
parallel to an oscilloscope, chart recorder, audio monitor, and digital
tape recorder for off-line analyses.
Extracellular RVLM unit recording and iontophoresis.
Extracellular recordings of single unit activity were made through a
single glass electrode filled with 0.5 M sodium acetate. For the
iontophoresis studies, the recording electrode was affixed to a
three-barrel electrode at a 20° angle with the tip extending 25 µm
below the remaining barrels. Of the nonrecording barrels, one contained
normal saline (0.9%) for balancing the ejection currents and the other
two contained the GABAA receptor agonist, muscimol (10 mM;
pH 6) and the GABAA receptor antagonist, bicuculline methiodide (20 mM, pH 3.0), respectively. Ejection and balancing currents were produced by a constant current source (Neuro Phore BH 2, Medical Systems; Greenvale, NY). The drugs were retained in the
electrode by applying a holding current of
5 nA and were ejected with
cationic currents.
RVLM neuronal recording protocols.
To determine whether PEH was due to a decrease in tonic central
sympathetic output, we recorded the spontaneous baseline activity of
sympathetic cardiovascular RVLM neurons during PEH and Sham PEH. All
RVLM neuronal recordings were commenced at ~4 h after the exercise or
sham-exercise period, owing to the initial transient anesthetic-induced
drop in MABP (that lasted ~2 h) (see Fig. 1).
|
Bicuculline iontophoreses protocols. In separate experiments from those used to establish the baroreflex function in SHR during PEH, we determined whether a GABAA receptor mechanism contributed to the tonic decrease in central sympathetic output of RVLM neurons and hence PEH. We compared the maximal effect of bicuculline on the baseline RVLM neuronal activity in PEH and Sham PEH animals. Each neuron was first tested with two doses (a low and high current) of muscimol before and during iontophoresis of bicuculline to confirm that 1) the neurons had GABAA receptors and that 2) the amount of bicuculline that maximally increased the neuronal spiking activity was sufficient to block GABAA-receptor-mediated decreases in neuronal activity (to verify that increases in spiking activity attributed to bicuculline were GABAA receptor mediated and not due to nonspecific effects of current injection or instability in the recording during iontophoresis). After a 2-min recovery period after muscimol ejections, bicuculline was iontophoretically applied with an ejection current starting at 10 nA. The current was progressively increased in 10- to 30-nA increments every 60- to 90-s interval until the minimum current was reached that maximally increased the spiking activity. Once that current was established, in every case, the current was then further increased by 10 nA to verify that further increase in the amount of antagonist had no further effect on spiking activity. Under constant bicuculline iontophoresis, RVLM unit activity was monitored over 2 min, and the response to muscimol was retested.
Data analysis. For the initial studies to determine whether PEH lasted 10 h in the conscious state, we used a two-way ANOVA with PEH and Sham PEH as one within factor and time as the other within factor. To determine whether PEH lasted 10 h in the anesthetized state, we also used a two-way ANOVA with PEH and Sham PEH as one between factor and time as the other within factor. To determine whether anesthesia affected the development of PEH, we averaged the 3 MABP values taken immediately before exercise and the 36 MABP values taken every 10 min between 4 and 10 h after exercise (PEH). The data were compared by using a two-way ANOVA with MABP as a within factor and with conscious versus anesthetized as a between factor. ANOVAs were followed by post-hoc tests when appropriate. Animal weights and blood gases were compared using an unpaired t-test.
For comparing spontaneous baseline RVLM neuronal firing frequency, unit activity was collected in 1-s bins, expressed as impulses per second (Hz), averaged over 2 min, and compared for neurons recorded during PEH and Sham PEH by using an unpaired t-test. Recording times for RVLM unit activity from the onset of anesthesia were also compared using an unpaired t-test. Raw LSNA voltage was rectified, integrated, and expressed as microvolts times seconds. Background instrumentation noise was determined after the rat was killed, and spontaneous LSNA was eliminated; this represented the zero reference point and was subtracted from LSNA before further analysis. LSNA, MABP, and HR averaged over 2 min were compared during PEH and Sham PEH using an unpaired t-test. RVLM-LSNA ratios and time from the R-wave to the peak unit activity and LSNA for PEH and Sham PEH were compared using unpaired t-tests. Complete stimulus-response curves were generated for RVLM unit activity and LSNA as a function of MABP. Reflex changes in LSNA and RVLM single unit activity to changes in MABP were fit to a sigmoid logistic function as described by Kent et al. (36) using SigmaPlot (Jandel) to allow for the comparison of various parameters used to assess baroreflex sensitivity between animals (18): the steady-state maximum activity (Max), the steady-state minimum activity (Min), the range of nerve activity, pressure at which neuronal activity was first decreased (Pth), and pressure at which neuronal activity was first maximally inhibited (Pcutoff). The maximum slope was used as an index of the sensitivity or maximum gain (Gmax) of the baroreflex function. The above parameters determined from curve-fit analysis of the function curves of PEH and Sham PEH groups were compared using an unpaired t-test. We further determined whether Gmax depended on a baseline firing rate in PEH or Sham PEH by linear regression analysis. To determine whether RVLM and LSNA activity remained related during PEH, LSNA was plotted as a function of RVLM neuronal activity for each neuron recorded during PEH and Sham PEH during phenylephrine- and nitroprusside-induced changes in MABP. Data points were fit by linear regression, and the slopes of the regression lines from PEH and Sham PEH neurons were compared using an unpaired t-test. To determine whether GABA acting at GABAA receptors contributed to the reduction in baseline RVLM unit activity in PEH, we compared the maximum bicuculline-induced increase in unit activity over baseline activity in PEH and Sham PEH using an unpaired t-test. The ejection currents used to achieve maximal unit responses to bicuculline during PEH and Sham PEH were compared with an unpaired t-test. The high-dose muscimol-induced decreases in unit activity were compared in each group using a paired t-test. The extent to which bicuculline prevented the muscimol-evoked unit responses was determined in each group by using an unpaired t-test. The currents used to achieve the high-dose muscimol inhibition of unit activity in PEH and Sham PEH were compared with an unpaired t-test. Linear regression analysis was used to determine whether the bicuculline-induced increases in firing activity depended on the baseline activity. Unless stated, all data are expressed as means ± SE. For all statistical tests, significance was claimed in analyses when the probability of a type 1 error was <0.05.| |
RESULTS |
|---|
|
|
|---|
PEH in conscious and anesthetized SHR. We confirmed previous findings (38, 43) demonstrating that PEH follows mild dynamic exercise in conscious SHR and extended those findings to show that the PEH lasted for at least 10 h (n = 4) in exercised rats and was not observed during sham exercise (n = 4) (Fig. 1A, two-way ANOVA with two-way repeated measures, P < 0.05, PEH vs. Sham PEH; P < 0.05, time; P < 0.05, interaction). At 10 h after exercise MABP was still lower than the control (preexercise values) in the PEH group (Fishers least signficant difference, P < 0.05) and was never lower than control in the Sham PEH group (Fishers least signficant difference, P > 0.05).
We further showed that PEH was still expressed when the SHR were anesthetized with mixture of
-chloralose (80 mg/kg) and urethane
(500 mg/kg) following exercise (Fig. 1B, two-way ANOVA with
one-way repeated measures, P < 0.05, PEH vs. Sham PEH;
P < 0.05, time; P < 0.05, interaction). As shown in Fig. 1B, the anesthetic induced a
transient fall in MABP in SHR in both the PEH (n = 4)
and Sham PEH (n = 5) groups that lasted ~2 h.
However, as was the case with the conscious animals, at 10 h after
exercise, MABP was still lower than the control (preexercise values) in the PEH group (Fisher's least-signficant difference, P < 0.05). In the Sham PEH group after the initial anesthetic-induced
decrease in MABP, the MABP was never lower than control (Fisher's
least-signficant difference, P > 0.05).
Finally, after the transient anesthetic-induced fall in MABP, the
magnitude and duration of PEH were not different in the conscious and
anesthetized rats (P > 0.05, conscious PEH vs.
anesthetized PEH; P < 0.05, time; P > 0.05, interaction). In the conscious PEH group, MABP was 170 ± 7 mmHg before exercise and 138 ± 9 mmHg after exercise (averaged
between 4 and 10 h). In the anesthetized PEH group, MABP was
168 ± 5 mmHg before exercise and was 143 ± 5 mmHg after
exercise (and the administration of the anesthetic) (averaged between 4 and 10 h). In the conscious Sham PEH group, MABP was 169 ± 10 mmHg before sham exercise and 173 ± 12 mmHg after exercise
(averaged between 4 and 10 h); and in the anesthetized Sham PEH
group, MABP was 165 ± 4 mmHg before sham exercise and 166 ± 10 mmHg during the corresponding 4- to 10-h period after sham exercise.
Sympathetic cardiovascular RVLM neuronal activity during PEH and Sham PEH. A total of 59 RVLM neurons considered to be cardiovascular sympathetic neurons based on a temporal relationship to LSNA and to the R-wave of the ECG were recorded in 37 SHR. Twenty-nine neurons were recorded from 18 SHR in the exercise group (PEH) and 30 neurons were recorded from 19 SHR in the sham-exercise group (Sham PEH). All neurons were studied between 4 and 10 h after anesthesia to avoid nonspecific changes in MABP owing to anesthetic. The mean time in which the RVLM neuronal recordings were made after anesthesia was 6.23 ± 0.27 h (range = 4.15-8.20 h) in the PEH group and 6.28 ± 0.27 h (range = 4.15-9.30 h) in the Sham PEH group. (P > 0.05 PEH vs. Sham PEH). Both PEH and Sham PEH animals had a similar weight distribution (PEH = 312 ± 9 g, Sham PEH = 309 ± 5 g; P > 0.05) and arterial blood gases (pH = 7.40 ± 0.01 vs. 7.39 ± 0.01; PCO2 = 39 ± 1.0 mmHg vs. 42 ± 2 mmHg; PO2 = 388 ± 29 mmHg vs. 363 ± 34 mmHg, respectively; P > 0.05).
Figure 2 shows examples of neurons recorded from Sham PEH and PEH. The spike-triggered averages of LSNA in Fig. 2A (top trace) illustrate the temporal relationship of the neuron and LSNA in a SHR during PEH and Sham PEH. In contrast, LSNA exhibited no consistent temporal relationship to random triggers delivered by a pulse generator at the same average frequency as that of the RVLM unit (Fig. 2A, bottom trace). As shown by the R-wave-triggered histograms (Fig. 2B), the neurons also displayed a cardiac rhythm, as did ABP and LSNA. The baseline firing activity, recorded at resting ABP, was 4.1 Hz for the neuron recorded during PEH and 12.7 Hz for the neuron recorded during Sham PEH (Fig. 2C, insets). The curve-fit data (Fig. 2C) show that the Gmax was 0.21 Hz/mmHg in the SHR with PEH and 0.34 Hz/mmHg in the SHR during the corresponding Sham PEH period. The maximum activity was 11.0 Hz during PEH and 28.1 Hz during Sham PEH.
|
|
|
1,
respectively. Neither the Pth nor Pcutoff were
different in the PEH or Sham PEH groups (P > 0.05).
The relationship between RVLM neuronal activity and LSNA was not
changed during PEH. When LSNA was plotted as a function of RVLM
neuronal activity for each neuron, the mean data yielded slopes that
were not different (0.09 ± 0.03 and 0.07 ± 0.02 for PEH and
Sham PEH neurons, respectively; P = 0.45).
Contribution of GABAA receptors on RVLM neuronal
activity during PEH.
The effects of GABAA-receptor antagonism on the baseline
spiking activity of sympathetic cardiovascular RVLM neurons were studied in 32 RVLM neurons from 19 SHR (18 neurons were recorded from 9 SHR in the PEH group and 14 from 10 SHR in the Sham PEH group). All
neurons were tested with muscimol before and during bicuculline to
verify the presence of GABAA receptors and to confirm that
the amount of bicuculline that maximally increased the neuronal spiking
activity was sufficient to block GABAA-receptor-mediated decreases in neuronal activity. An example of the neuronal responses to
muscimol and bicuculline in an SHR from the PEH and Sham PEH group is
shown in Fig. 5.
|
)
in firing activity over the baseline firing activity in RVLM neurons in
the PEH and Sham PEH groups are shown in Fig. 6. In the PEH group
(n = 18), bicuculline increased the baseline activity
(4.9 ± 1.1 Hz) to a maximum of 33.1 ± 4.4 Hz (
= 28 ± 4 Hz); the increase over baseline was significantly greater compared with that in the Sham PEH group (n = 14),
where bicuculline increased the baseline activity of 14.8 ± 4.5 Hz to a maximum of 28.1 ± 5.1 Hz (
= 13 ± 2 Hz)
(P < 0.05,
PEH vs.
Sham PEH). The maximal level
of firing activity was not different in the PEH and Sham PEH groups;
however, the baseline activity, as expected, was lower in the PEH
compared with the Sham PEH group (P < 0.05). The
bicuculline-induced increase in firing rate in neurons in the Sham PEH
or PEH group was not dependent on the baseline firing rate in either
group (r2 = 0.02; P = 0.61 for Sham PEH; r2 = 0.001, P = 0.90 for PEH). In addition, in neurons with similar baseline
activities recorded during PEH [5.6 ± 1.2 (SD) Hz] and Sham PEH
[7.5 ± 1.2 (SD) Hz] the bicuculline-induced increase was still
greater in PEH compared with Sham PEH (29.2 ± 5.7 Hz for PEH vs.
14.4 ± 2.6 Hz for Sham PEH, P = 0.04). The
maximum current for ejecting bicuculline was not different in the two groups, averaging 71 ± 5 nA in the PEH group and 72 ± 7 nA
in the Sham PEH group (P > 0.05).
|
| |
DISCUSSION |
|---|
|
|
|---|
This study provides new data on central neural mechanisms contributing to PEH. First, cardiovascular sympathetic neurons in the RVLM demonstrated a significant decrease in their spontaneous firing activity along with a reduced LSNA during PEH. Second, this reduced RVLM neuronal activity was mediated, at least in part, by a GABAA-receptor mechanism. Third, baroreceptor reflex control of the RVLM sympathetic cardiovascular neuronal activity and sympathetic output operated with a significantly reduced gain and range during PEH.
A reduction in sympathetic nerve activity is a salient feature of PEH
(20, 29, 32, 38) and has been proposed to mediate PEH
(10). One important site where the level of sympathetic nerve activity can be decreased is the RVLM central sympathetic network. During PEH, RVLM sympathetic cardiovascular neurons exhibited a significantly reduced resting activity compared with the
corresponding Sham PEH period; this reduced activity was accompanied by
reduced LSNA, suggesting that a decreased central sympathetic outflow from the RVLM contributes to PEH. To allow for recording from the RVLM
neurons, the experiments were performed in
-chloralose- and
urethane-anesthetized SHR. After an initial anesthetic-induced fall in
ABP, both the magnitude and duration of PEH were the same in the
anesthetized and conscious SHR.
To our knowledge, this is the first study to implicate an exaggerated contribution of GABAA signaling at functionally identified cardiovascular sympathetic RVLM neurons as a mechanism contributing to PEH. It is well established that RVLM neurons are under a tonic GABA-ergic inhibitory influence, largely (2, 15, 24, 26, 45), though not exclusively, via a baroreceptor input (40). In the present study, the maximal increase in firing activity of RVLM neurons in response to bicuculline was significantly greater during PEH compared with Sham PEH, suggesting that a tonically active GABAA-receptor mechanism contributed to the reduction in RVLM neuronal output. Had other non-GABA-ergic mechanisms contributed importantly, the maximal dose of bicuculline should have increased the neuronal activity to the same extent during PEH or Sham PEH. In addition, even in neurons with similar baseline activities recorded during PEH and Sham PEH, the bicuculline-induced increase was still greater in the PEH neurons, suggesting that a reduced baseline activity alone did not explain the exaggerated bicuculline responses in PEH.
A limitation of the iontophoretic ejection technique is that the actual amount of drug ejected is not determined; however, the ranges for iontophoretic ejection currents for bicuculline were the same in the recordings from neurons in the PEH and Sham PEH group. In addition, after neuronal activity was judged to be maximally increased, increasing the bicuculline ejection current further had no effect on the spiking activity. For these reasons, it seems unlikely that different amounts of drug were ejected in the two groups, but rather more likely that equivalent amounts of bicuculline had a greater effect at RVLM synapses during PEH compared with Sham PEH.
The critical nature of an intact baroreflex system for the development of PEH was explicitly demonstrated by DiCarlo's group (10). Whether the absence of baroreceptor afferent input directly altered the behavior of neurons in the central baroreflex network or somehow triggered other central mechanisms is not known. Whatever the nature of the effects, the gain of baroreflex control of sympathetic nerve activity appears to be blunted both in humans and SHR (10, 29). In the current study, the baroreceptor stimulus-response curves demonstrated a marked reduction in the gain of baroreflex control of RVLM neuronal activity, which most likely accounted for the reduced gain of LSNA. The question arises as to whether the increased GABA inhibitory influence on baseline RVLM neuronal activity during PEH contributed to the attendant reduced baroreflex gain, or were the two unrelated? Whereas the baroreflex function curve represents dynamic changes, it seems reasonable to consider that a tonic enhancement of nonbaroreceptor GABA-mediated inhibition of RVLM neuronal activity during PEH could reduce the maximal activity associated with baroreceptor unloading, thereby decreasing the range of baroreflex function and hence the gain. On the other hand, for RVLM neurons with similar baseline activities in the PEH and Sham PEH groups, the Gmax was still significantly lower in the PEH group, suggesting that the reduced Gmax cannot be explained by a reduced range. Thus, on balance, the data are consistent with the idea that an enhanced GABA-ergic influence contributed to the reduced baroreflex gain.
Given that hypertension and exercise are the two key elements for the development of PEH, the relationship of the baroreflexes and sympathetic nerve activity in hypertension and during exercise may be relevant to resolving the mechanisms of PEH. There is extensive evidence that the baroreflex system, viewed as a whole, resets to higher blood pressures during hypertension (39) and exercise (16, 46, 50, 53).
The resetting in hypertension has been suggested to occur at the level of the peripheral baroreceptors (4, 12, 37, 42, 52, 57), although there are also data for central resetting (1, 12, 39). The resetting during exercise has been uniformly proposed to occur in the central nervous system, whether attributed to central command (51) or to skeletal muscle afferents (49, 50) or to both (41). It is tempting to speculate that exercise against a background of hypertension sets in motion some immediate, yet relatively long-lasting (up to 10 h) changes, including in GABA signaling, in the central nervous system that triggers the development of PEH. In that regard, Overton and colleagues (44) reported that microinjection of the GABAA receptor agonist, muscimol, in the posterior hypothalamus during exercise produced postexercise behavioral effects, including a mild sedation, that was attributed to GABA. Viewed collectively, the findings suggest that GABA signaling may be altered at various neural networks during exercise.
A number of other central nervous system neurotransmitter systems could contribute to PEH, including one other inhibitory neurotransmitter glycine (58). On the other hand, the opioid system in PEH has received considerable attention, particularly since elevated endorphins have been reported during exercise (3). The opioid antagonist, naloxone, given intravenously has been shown to attenuate PEH to varying degrees following exercise in humans (31) and SHR (56). These findings have led to the suggestion that central endorphins might initiate the decrease in central sympathetic outflow during PEH. Both GABAA (15, 24, 45, 58, 59) and µ-opioid receptors are located on RVLM sympathetic cardiovascular neurons and have been colocalized in rat brain stem (34). In addition, results from physiological and neurochemical studies provide evidence for an interaction between GABAA and µ-opioid receptor systems (6, 17, 60). These findings raise the possibility that redundant and interactive opioid and GABAA receptor mechanisms in the RVLM may contribute to PEH.
In conclusion, the results of this study suggest that upregulation of aspects of GABA signaling at sympathetic cardiovascular RVLM neurons lead to a decreased neuronal output that may contribute to the decrease in sympathetic outflow and hence PEH. Moreover, the effect appears to last at least 10 h.
| |
ACKNOWLEDGEMENTS |
|---|
The authors gratefully acknowledge the excellent technical assistance of Judy Stewart.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute HL-67183 to A. C. Bonham and an American Heart Association, Western Affiliate, Postdoctoral Fellowship 0020004Y to C.-Y. Chen.
Address for reprint requests and other correspondence: A. C. Bonham, Dept. of Internal Medicine, Division of Cardiovascular Medicine, One Shields Ave., TB172, Univ. of California at Davis, Davis, CA 95616 (E-mail: acbonham{at}ucdavis.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published January 17, 2002;10.1152/ajpheart.00725.2001
Received 13 August 2001; accepted in final form 14 January 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abboud, FM.
The sympathetic system in hypertension.
Hypertension
4:
208-225,
1982.
2.
Aicher, SA,
Milner TA,
Pickel VM,
and
Reis DJ.
Anatomical substrates for baroreflex sympathoinhibition in the rat.
Brain Res Bull
51:
107-110,
2000.
3.
Allen, M.
Activity generated endorphins: a review of their role in sports science.
Can J Appl Sports Sci
8:
115-133,
1983.
4.
Andresen, MC,
Kuraoka S,
and
Brown AM.
Baroreceptor function and changes in strain sensitivity in normotensive and spontaneously hypertensive rats.
Circ Res
47:
821-828,
1980.
5.
Appel, LJ.
Nonpharmacologic therapies that reduce blood pressure: a fresh perspective.
Clin Cardiol
22:
III1-III5,
1999.
6.
Arenas, E,
Marsal J,
and
Alberch J.
GABAA and GABAB antagonists prevent the opioid inhibition of endogenous acetylcholine release evoked by glutamate from rat neostriatal slices.
Neurosci Lett
120:
201-204,
1990.
7.
Bennett, T,
Wilcox RG,
and
MacDonald IA.
Post-exercise reduction of blood pressure in hypertensive men is not due to acute impairment of baroreflex function.
Clin Sci (Lond)
67:
97-103,
1984.
8.
Boone, JB, Jr,
Levine M,
Flynn MG,
Pizza FX,
Kubitz ER,
and
Andres FF.
Opioid receptor modulation of postexercise hypotension.
Med Sci Sports Exerc
24:
1108-1113,
1992.
9.
Boone, JB,
Probst MM,
Rogers MW,
and
Berger R.
Postexercise hypotension reduces cardiovascular responses to stress.
J Hypertens
11:
449-453,
1993.
10.
Chandler, MP,
and
DiCarlo SE.
Sinoaortic denervation prevents postexercise reductions in arterial pressure and cardiac sympathetic tonus.
Am J Physiol Heart Circ Physiol
273:
H2738-H2745,
1997.
11.
Chandler, MP,
Rodenbaugh DW,
and
DiCarlo SE.
Arterial baroreflex resetting mediates postexercise reductions in arterial pressure and heart rate.
Am J Physiol Heart Circ Physiol
275:
H1627-H1634,
1998.
12.
Chapleau, MW,
Cunningham JT,
Sullivan MJ,
Wachtel RE,
and
Abboud FM.
Structural versus functional modulation of the arterial baroreflex.
Hypertension
26:
341-347,
1995.
13.
Cleroux, J,
Kouame N,
Nadeau A,
Coulombe D,
and
Lacourciere Y.
Aftereffects of exercise on regional and systemic hemodynamics in hypertension.
Hypertension
19:
183-191,
1992.
14.
Collins, HL,
and
DiCarlo SE.
Attenuation of postexertional hypotension by cardiac afferent blockade.
Am J Physiol Heart Circ Physiol
265:
H1179-H1183,
1993.
15.
Dampney, RA.
Functional organization of central pathways regulating the cardiovascular system.
Physiol Rev
74:
323-364,
1994.
16.
DiCarlo, SE,
and
Bishop VS.
Onset of exercise shifts operating point of arterial baroreflex to higher pressures.
Am J Physiol Heart Circ Physiol
262:
H303-H307,
1992.
17.
Dingledine, R,
Iversen LL,
and
Breuker E.
Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies.
Eur J Pharmacol
47:
19-27,
1978.
18.
Farah, VM,
Moreira ED,
Pires MD,
Irigoyen MC,
and
Krieger EM.
Comparison of three methods for the determination of baroreflex sensitivity in conscious rats.
Braz J Med Biol Res
32:
361-369,
1999.
19.
Fitzgerald, W.
Labile hypertension and jogging: new diagnostic tool or spurious discovery.
Br Med J
282:
542-544,
1981.
20.
Floras, JS,
Sinkey CA,
Aylward PE,
Seals DR,
Thoren PN,
and
Mark AL.
Postexercise hypotension and sympathoinhibition in borderline hypertensive men.
Hypertension
14:
28-35,
1989.
21.
Franklin, PJ,
Green DJ,
and
Cable NT.
The influence of thermoregulatory mechanisms on post-exercise hypotension in humans.
J Physiol (Lond)
470:
231-241,
1993.
22.
Gebber, GL,
and
Barman SM.
Sympathetic-related activity of brain stem neurons in baroreceptor-denervated cats.
Am J Physiol Regulatory Integrative Comp Physiol
240:
R348-R355,
1981.
23.
Granata, AR.
Effects of gamma-aminobutyric acid on putative sympatho-excitatory neurons in the rat rostral ventrolateral medulla in vitro. Intracellular study.
Neurosci Lett
300:
49-53,
2001.
24.
Guyenet, PG.
Role of the ventral medulla oblongata in blood pressure regulation.
In: Central Regulation of Autonomic Functions, edited by Loewy AD,
and Spyer KM.. New York: Oxford University Press, 1990, p. 145-167.
25.
Guyenet, PG,
Darnall RA,
and
Riley TA.
Rostral ventrolateral medulla and sympathorespiratory integration in rats.
Am J Physiol Regulatory Integrative Comp Physiol
259:
R1063-R1074,
1990.
26.
Guyenet, PG,
Filtz TM,
and
Donaldson SR.
Role of excitatory amino acids in rat vagal and sympathetic baroreflexes.
Brain Res
407:
272-284,
1987.
27.
Guyenet, PG,
Haselton JR,
and
Sun MK.
Sympathoexcitatory neurons of the rostroventrolateral medulla and the origin of the sympathetic vasomotor tone.
Prog Brain Res
81:
105-116,
1989.
28.
Hagberg, JM,
Montain SJ,
and
Martin WH, III.
Blood pressure and hemodynamic responses after exercise in older hypertensive men.
J Appl Physiol
63:
270-276,
1987.
29.
Halliwill, JR,
Taylor JA,
and
Eckberg DL.
Impaired sympathetic vascular regulation in humans after acute dynamic exercise.
J Physiol (Lond)
495.1:
279-288,
1996.
30.
Hannum, SM,
and
Kasch FW.
Acute postexercise blood pressure response of hypertensive and normotensive men.
Scand J Sports Sci
3:
11-15,
1981.
31.
Hara, K,
and
Floras JS.
Effects of naloxone on hemodynamics and sympathetic activity after exercise.
J Appl Physiol
73:
2028-2035,
1992.
32.
Hara, K,
and
Floras JS.
Influence of naloxone on muscle sympathetic nerve activity, systemic and calf hemodynamics and ambulatory blood pressure after exercise in mild essential hypertension.
J Hypertens
13:
447-461,
1995.
33.
Howard, MG,
and
DiCarlo SE.
Reduced vascular responsiveness after a single bout of dynamic exercise in the conscious rabbit.
J Appl Physiol
73:
2662-2667,
1992.
34.
Kalyuzhny, AE,
Dooyema J,
and
Wessendorf MW.
Opioid- and GABA(A)-receptors are co-expressed by neurons in rat brain.
Neuroreport
11:
2625-2628,
2000.
35.
Kaufman, FL,
Hughson RL,
and
Schaman JP.
Effect of exercise on recovery blood pressure in normotensive and hypertensive subjects.
Med Sci Sports Exerc
19:
17-20,
1987.
36.
Kent, BB,
Drane JW,
Blumenstein B,
and
Manning JW.
A mathematical model to assess changes in the baroreceptor reflex.
Cardiology
57:
295-310,
1972.
37.
Kezdi, P.
Sinoaortic regulatory system: role in pathogenesis of essential and malignant hypertension.
Arch Intern Med
91:
26-34,
1953.
38.
Kulics, JM,
Collins HL,
and
DiCarlo SE.
Postexercise hypotension is mediated by reductions in sympathetic nerve activity.
Am J Physiol Heart Circ Physiol
276:
H27-H32,
1999.
39.
Kunze, DL.
Acute resetting of baroreceptor reflex in rabbits: a central component.
Am J Physiol Heart Circ Physiol
250:
H866-H870,
1986.
40.
Lipski, J,
Kanjhan R,
Kruszewska B,
and
Rong W.
Properties of presympathetic neurones in the rostral ventrolateral medulla in the rat: an intracellular study "in vivo".
J Physiol (Lond)
490:
729-744,
1996.
41.
McIlveen, SA,
Hayes SG,
and
Kaufman MP.
Both central command and exercise pressor reflex reset carotid sinus reflex.
Am J Physiol Heart Circ Physiol
280:
H1454-H1463,
2001.
42.
Nosaka, S,
and
Wang SC.
Carotid sinus baroreceptor function in the spontaneously hypertensive rat.
Am J Physiol
222:
1079-1084,
1972.
43.
Overton, JM,
Joyner MJ,
and
Tipton CM.
Reductions in blood pressure after acute exercise by hypertensive rats.
J Appl Physiol
64:
748-752,
1988.
44.
Overton, JM,
Redding MW,
Yancey SL,
and
Stremel RW.
Hypothalamic GABAergic influences on treadmill exercise responses in rats.
Brain Res Bull
33:
517-522,
1994.
45.
Owens, NC,
and
Verberne AJ.
Medial prefrontal depressor response: involvement of the rostral and caudal ventrolateral medulla in the rat.
J Auton Nerv Syst
78:
86-93,
2000.
46.
Papelier, Y,
Escourrou P,
Gauthier JP,
and
Rowell LB.
Carotid baroreflex control of blood pressure and heart rate in men during dynamic exercise.
J Appl Physiol
77:
502-506,
1994.
47.
Peng, YJ,
Gong QL,
and
Li P.
GABA(A) receptors in the rostral ventrolateral medulla mediate the depressor response induced by stimulation of the greater splanchnic nerve afferent fibres in rats.
Neurosci Lett
249:
95-98,
1998.
48.
Pescatello, LS,
Fargo AE,
Leach CN,
and
Scherzer HH.
Short-term effect of dynamic exercise on arterial blood pressure.
Circulation
83:
1557-1561,
1991.
49.
Potts, JT,
Fuchs IE,
Li J,
Leshnower B,
and
Mitchell JH.
Skeletal muscle afferent fibres release substance P in the nucleus tractus solitarii of anaesthetized cats.
J Physiol (Lond)
514.3:
829-841,
1999.
50.
Potts, JT,
Shi XR,
and
Raven PB.
Carotid baroreflex responsiveness during dynamic exercise in humans.
Am J Physiol Heart Circ Physiol
265:
H1928-H1938,
1993.
51.
Rowell, LB,
and
O'Leary DS.
Reflex control of the circulation during exercise: chemoreflexes and mechanoreflexes.
J Appl Physiol
69:
407-418,
1990.
52.
Sapru, HN,
and
Wang SC.
Modification of aortic baroreceptor resetting in the spontaneously hypertensive rat.
Am J Physiol
230:
664-674,
1976.
53.
Scherrer, U,
Pryor SL,
Bertocci LA,
and
Victor RG.
Arterial baroreflex buffering of sympathetic activation during exercise-induced elevations in arterial pressure.
J Clin Invest
86:
1855-1861,
1990.
54.
Schreihofer, AM,
Stornetta RL,
and
Guyenet PG.
Regulation of sympathetic tone and arterial pressure by rostral ventrolateral medulla after depletion of C1 cells in rat.
J Physiol (Lond)
529:
221-236,
2000.
55.
Schwartz, GL,
and
Sheps SG.
A review of the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Curr Opin Cardiol
14:
161-168,
1999.
56.
Shyu, BC,
and
Thorén P.
Circulatory events following spontaneous muscle exercise in normotensive and hypertensive rats.
Acta Physiol Scand
128:
515-524,
1976.
57.
Sun, MK,
and
Guyenet PG.
Medullospinal sympathoexcitatory neurons in normotensive and spontaneously hypertensive rats.
Am J Physiol Regulatory Integrative Comp Physiol
250:
R910-R917,
1986.
58.
Sun, MK,
and
Guyenet PG.
GABA-mediated baroreceptor inhibition of reticulospinal neurons.
Am J Physiol Regulatory Integrative Comp Physiol
249:
R672-R680,
1985.
59.
Sun, MK,
and
Guyenet PG.
Effect of clonidine and gamma-aminobutyric acid on the discharges of medullo-spinal sympathoexcitatory neurons in the rat.
Brain Res
368:
1-17,
1986.
60.
Ticku, MK,
and
Huffman RD.
The effects of acute and chronic morphine administration on GABA receptor binding.
Eur J Pharmacol
68:
97-106,
1980.
61.
Wang, QA,
and
Li P.
A GABAergic mechanism in the inhibition of cardiac vagal reflexes.
Brain Res
457:
367-370,
1988.
This article has been cited by other articles:
![]() |
C.-Y. Chen, A. G. Bechtold, J. Tabor, and A. C. Bonham Exercise Reduces GABA Synaptic Input onto Nucleus Tractus Solitarii Baroreceptor Second-Order Neurons via NK1 Receptor Internalization in Spontaneously Hypertensive Rats J. Neurosci., March 4, 2009; 29(9): 2754 - 2761. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Kimmerly, S. W. Wong, D. Salzer, R. Menon, and J. K. Shoemaker Forebrain regions associated with postexercise differences in autonomic and cardiovascular function during baroreceptor unloading Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H299 - H306. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Mueller Exercise training attenuates increases in lumbar sympathetic nerve activity produced by stimulation of the rostral ventrolateral medulla J Appl Physiol, February 1, 2007; 102(2): 803 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Mueller and E. M. Hasser Putative role of the NTS in alterations in neural control of the circulation following exercise training in rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R383 - R392. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Williamson, R. McColl, and D. Mathews Changes in regional cerebral blood flow distribution during postexercise hypotension in humans J Appl Physiol, February 1, 2004; 96(2): 719 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miki, M. Yoshimoto, and M. Tanimizu Acute shifts of baroreflex control of renal sympathetic nerve activity induced by treadmill exercise in rats J. Physiol., April 1, 2003; 548(1): 313 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Masuki, M. Takeoka, S.'I. Taniguchi, and H. Nose Enhanced baroreflex sensitivity in free-moving calponin knockout mice Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H939 - H946. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Chen, P. A. Munch, A. W. Quail, and A. C. Bonham Postexercise hypotension in conscious SHR is attenuated by blockade of substance P receptors in NTS Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1856 - H1862. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |